Santosh Karnewar, Vaishnavi Karnewar, Rebecca Deaton, Laura S Shankman, Ernest D Benavente, Corey M Williams, Xenia Bradley, Gabriel F Alencar, Gamze B Bulut, Sara Kirmani, Richard A Baylis, Eli R Zunder, Hester M den Ruijter, Gerard Pasterkamp, Gary K Owens
BACKGROUND: Thromboembolic events secondary to rupture or erosion of advanced atherosclerotic lesions is the global leading cause of death. The most common and effective means to reduce these major adverse cardiovascular events, including myocardial infarction and stroke, is aggressive lipid lowering via a combination of drugs and dietary modifications. However, we know little regarding the effects of reducing dietary lipids on the composition and stability of advanced atherosclerotic lesions, the mechanisms that regulate these processes, and what therapeutic approaches might augment the benefits of lipid lowering...
May 2, 2024: Arteriosclerosis, Thrombosis, and Vascular Biology